Population
Human osteosarcoma cells
Comparison
IGFBP-5 siRNA and/or addition of exogenous IGFBP-5 vs Control cells, wild type IGFBP-5 overexpression…
Design
Preclinical
Authors
Loading...
Preliminary cell findings leave IGFBP-5 targeting open; in vivo validation required before any translational consideration.
Endogenous and exogenous IGFBP-5 exhibit opposing biological actions on cell survival in human osteosarcoma cells, highlighting the importance of loss-of-function approaches.
Yin et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: